Tempus AI, based in Chicago, Illinois, went public on June 14, 2024, providing next-generation diagnostics through genomics and AI applications aimed at personalizing medicine. Its primary product, Next, uses machine learning to enhance oncology and cardiology care.
Ryan M Bartolucci sold 13,770 shares of TEM on 31 January at $60.00 per share, worth a total of $826K. They now own 57,237 TEM shares, or a 19% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
